Clinical Trial Update: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

Pilot Phase 1/2 clinical trial examining cannabidiol for the treatment of diabetic peripheral neuropathy; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Florida A&M University | Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING